The ITSCON 2026 Scientific Programme has been thoughtfully curated to reflect the breadth and evolving landscape of thyroidology, with a focused emphasis on advancing clinical practice, surgical precisionand translational research in thyroid disorders. The programme is designed to engage a diverse audience, including Endocrinologists, Endocrine Surgeons, Nuclear Medicine specialists, Physicians, trainees, and academic researchers.
The conference will host renowned international experts alongside eminent national faculty, offering insights that span the translational continuum - from molecular mechanisms and emerging diagnostics to evidence-based clinical management and long-term outcomes in thyroid disease.
Over two days, ITSCON 2026 will deliver a rich academic experience featuring plenary lectures, keynote addresses, thematic symposia, case-based panel discussions, interactive debates, and focused workshops. The programme highlights contemporary challenges and innovations in thyroid disorders, with particular relevance to clinical practice in the Indian setting.The programme not only highlights scientific excellence but also encourages dialogue, mentorship, and the development of future leaders in thyroidology.
- Thyroid nodules: evaluation, risk stratification, and management
- Differentiated thyroid cancer: updates in diagnosis and treatment
- Graves' disease and orbitopathy: advances in management
- Hypothyroidism and subclinical thyroid disease
- Thyroid dysfunction in pregnancy and postpartum
- Pediatric thyroid disorders
- Iodine nutrition and public health perspectives
- Thyroid imaging and cytopathology (USG, FNAC, molecular markers)
- Radioiodine therapy and nuclear medicine advances
- Surgical approaches in thyroid disease and complication management
- Emerging targeted therapies and precision medicine in thyroid cancer
- Future directions in the management of differentiated thyroid cancer
- Individualising therapy in Graves' disease: beyond conventional approaches
- Advances in molecular diagnostics in thyroid nodules
- Redefining TSH targets: clinical implications across populations
- Thyroid disease in pregnancy: balancing maternal and fetal outcomes
- Active surveillance vs early intervention in low-risk thyroid cancer
- Extent of surgery in differentiated thyroid cancer: how much is enough?
- Managing subclinical hypothyroidism: when to treat?
- Thyroid eye disease: multidisciplinary care models
- Role of molecular testing in indeterminate thyroid nodules
- Long-term follow-up strategies in thyroid cancer survivors
- Extent of surgery in differentiated thyroid cancer: evolving consensus
- Management of subclinical hypothyroidism: evidence vs practice
- Thyroid eye disease: a multidisciplinary approach
- Recurrent and persistent thyroid cancer
- Indeterminate thyroid nodules: diagnostic dilemmas
- Thyroid dysfunction in special populations
- Challenging post-thyroidectomy complications
- Thyroid disorders in pregnancy: real-world scenarios
- Thyroid ultrasound: hands-on interpretation and risk stratification
- Fine needle aspiration cytology (FNAC) techniques and reporting
- Surgical anatomy and intraoperative decision-making
- Multidisciplinary tumour board simulations
Debates
- Should all low-risk thyroid cancers be actively followed-up?
- Total thyroidectomy vs hemithyroidectomy: what is appropriate in an Indian context?
- Is radioiodine therapy overused in differentiated thyroid cancer?
- Should subclinical hypothyroidism always be treated?
